Cardlytics, Inc. reported impairment charges for the fourth quarter ended December 31, 2023. For the quarter, the company reported impairment of goodwill and intangible assets of $70,518,000 against $370,139,000 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.6 USD | -5.26% | +12.39% | +58.52% |
May. 08 | (CDLX) CARDLYTICS Expects Q2 Revenue Range $73M - $81M | MT |
May. 08 | Earnings Flash (CDLX) CARDLYTICS Posts Q1 Revenue $67.6M, vs. Street Est of $71.7M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+58.52% | 742M | |
+9.17% | 3,042B | |
+6.91% | 83.84B | |
+3.74% | 77.3B | |
-13.64% | 53.92B | |
-24.95% | 47.93B | |
+25.57% | 47.66B | |
+19.54% | 43.81B | |
+64.81% | 37.42B | |
-14.63% | 25.93B |
- Stock Market
- Equities
- CDLX Stock
- News Cardlytics, Inc.
- Cardlytics, Inc. Reports Impairment Charges for the Fourth Quarter Ended December 31, 2023